Edgewise Therapeutics, Inc.EWTXNASDAQ
Loading
Current Ratio Over TimeFair Value
Percentile Rank17
3Y CAGR-2.7%
5Y CAGR-7.8%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
-2.7%/yr
Annual compound
5Y CAGR
-7.8%/yr
Recent acceleration
Percentile
P17
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineFair Value
PeriodValueYoY Change
202519.85-0.4%
202419.93+2.2%
202319.50-9.4%
202221.53-20.2%
202126.97-9.7%
202029.86+40.6%
201921.24-